Zobrazeno 1 - 10
of 164
pro vyhledávání: '"Ann O'Riordan"'
Autor:
Ann O'Riordan, Rudi Gasser
Publikováno v:
Tobacco Induced Diseases, Vol 16, Iss 1 (2018)
Background and challenges to implementation Tobacco use is highly addictive and harms every organ in the body. Tobacco users are therefore likely high among healthcare users and look to health professionals first for help and support. To effectively
Externí odkaz:
https://doaj.org/article/1da24da4f9684937ab1a3839a1f48382
Autor:
George A. Yendewa, J. McLeod Griffiss, Michael R. Jacobs, Scott A. Fulton, Mary Ann O’Riordan, Wesley A. Gray, Howard M. Proskin, Peter Winkle, Robert A. Salata
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 21, Iss , Pp 171-180 (2020)
Objectives: Successful decolonisation of nasal Staphylococcus aureus (SA) carriage by mupirocin is limited by increasing drug resistance. This randomised, open-label, phase 1 study compared the safety and local tolerability of two nasal formulations
Externí odkaz:
https://doaj.org/article/b12da190978849c5b32131201d720d1d
Autor:
George A. Yendewa, John McLeod Griffiss, Wesley A. Gray, Amanda Healen, Howard M. Proskin, Scott A. Fulton, Mary Ann O’Riordan, Charles Hoppel, Jeffrey L. Blumer, Robert A. Salata
Publikováno v:
Antibiotics, Vol 11, Iss 4, p 490 (2022)
Despite its use for decades, pharmacokinetic (PK) and safety studies on colistin are limited. We conducted a phase l, open-label trial to evaluate the safety and PK of multiple doses of intravenous (IV) and aerosolized colistimethate sodium (CMS) adm
Externí odkaz:
https://doaj.org/article/a501e72d52d34d9da3034a68b775a9e7
Autor:
Bryan C. Hambley, Rania Abdul Rahman, Maxwell Reback, Mary Ann O’Riordan, Nathan Langer, Robert C. Gilkeson, Mahazarin Ginwalla, Jane A. Little, Robert Schilz
Publikováno v:
Haematologica, Vol 104, Iss 1 (2019)
Externí odkaz:
https://doaj.org/article/3467d997b2914b9bb5fe33067ca64bd8
Publikováno v:
Journal of adolescent and young adult oncology. 10(6)
Purpose: Adolescent and young adult (AYA) patients (15-39 years old) with acute lymphoblastic leukemia (ALL) have less favorable outcomes and higher treatment-related mortality as compared with older children with ALL. Minimal data exist regarding ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0de0db621bab35c9e54c50df0e6eca4f
https://pubmed.ncbi.nlm.nih.gov/33512257
https://pubmed.ncbi.nlm.nih.gov/33512257
Publikováno v:
Clinical and experimental rheumatology. 39(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::491350cfe33e3d806af90e500a8d83a8
https://pubmed.ncbi.nlm.nih.gov/33634779
https://pubmed.ncbi.nlm.nih.gov/33634779
Publikováno v:
Clinical and experimental rheumatology. 39(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2d42aa5139a7aa84162141e5179b498b
https://pubmed.ncbi.nlm.nih.gov/33506757
https://pubmed.ncbi.nlm.nih.gov/33506757
Autor:
Heather Y Hughes, Julia C. Kosco, Grace A. McComsey, Nancy L Hagood, Sarah E Scott, Allison Ross Eckard, Danielle Labbato, Mary Ann O'Riordan
Publikováno v:
J Acquir Immune Defic Syndr
Background Fecal calprotectin (FC), a biomarker of gastrointestinal (GI) inflammation, is used in the diagnosis and management of inflammatory bowel disease. HIV infection severely damages gut-associated lymphoid and epithelial tissues leading to GI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3edabd8966039c8ed44947a41e7e39
https://pubmed.ncbi.nlm.nih.gov/33065582
https://pubmed.ncbi.nlm.nih.gov/33065582
Autor:
Sarah E Scott, Allison Ross Eckard, Heather Y. Hughes, Danielle Labbato, Grace A. McComsey, Julia C. Kosco, Nancy L Hagood, Mary Ann O'Riordan
Publikováno v:
J Acquir Immune Defic Syndr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fb8afc69d275512969825ae7468edae
https://europepmc.org/articles/PMC7153762/
https://europepmc.org/articles/PMC7153762/
Autor:
Robert A. Salata, Jeffrey L. Blumer, Mary Ann O'Riordan, Wesley A. Gray, Howard M. Proskin, Amanda M. Healan, J. McLeod Griffiss
Publikováno v:
Clinical Pharmacology in Drug Development. 8:436-442
There is an urgent need to identify safe and effective combination treatments for multidrug-resistant (MDR) Mycobacterium tuberculosis infection (TB). Bedaquiline, a new diarylquinoline, is approved for the treatment of MDR pulmonary TB in combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfec9f131c75969517468cc8656ffe02
https://doi.org/10.1002/cpdd.639
https://doi.org/10.1002/cpdd.639